Cory Jubinville, PhD
Stock Analyst at LifeSci Capital
(4.79)
# 529
Out of 4,512 analysts
164
Total ratings
60.8%
Success rate
29%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cory Jubinville, PhD
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRME Prime Medicine | Maintained: Buy | $6 | $3.52 | +70.70% | 8 | Jul 11, 2026 | |
| TNYA Tenaya Therapeutics | Maintained: Buy | $4 | $0.8365 | +378.18% | 31 | Jun 3, 2026 | |
| MREO Mereo BioPharma Group | Maintained: Hold | n/a | $0.321 | - | 14 | Jan 12, 2026 | |
| CRNX Crinetics Pharmaceuticals | Maintained: Buy | $93 → $99 | $83.67 | +18.32% | 30 | Jan 5, 2026 | |
| SION Sionna Therapeutics | Initiated Coverage: Buy | $60 | $43.95 | +36.52% | 1 | Dec 23, 2025 | |
| IKT Inhibikase Therapeutics | Initiated Coverage: Buy | $5 | $1.96 | +155.10% | 1 | Dec 1, 2025 | |
| TECX Tectonic Therapeutic | Maintained: Buy | $88 | $34.34 | +156.26% | 5 | Nov 18, 2025 | |
| RCKT Rocket Pharmaceuticals | Maintained: Buy | $9 | $3.72 | +141.94% | 17 | Nov 7, 2025 | |
| LRMR Larimar Therapeutics | Maintained: Buy | $22 | $3.73 | +490.60% | 21 | Nov 5, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintained: Buy | $85 → $84 | $59.31 | +41.63% | 14 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $67 | $71.21 | -5.91% | 22 | Nov 3, 2025 |
Prime Medicine
Jul 11, 2026
Maintained: Buy
Price Target: $6
Current: $3.52
Upside: +70.70%
Tenaya Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: $4
Current: $0.8365
Upside: +378.18%
Mereo BioPharma Group
Jan 12, 2026
Maintained: Hold
Price Target: n/a
Current: $0.321
Upside: -
Crinetics Pharmaceuticals
Jan 5, 2026
Maintained: Buy
Price Target: $93 → $99
Current: $83.67
Upside: +18.32%
Sionna Therapeutics
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $60
Current: $43.95
Upside: +36.52%
Inhibikase Therapeutics
Dec 1, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.96
Upside: +155.10%
Tectonic Therapeutic
Nov 18, 2025
Maintained: Buy
Price Target: $88
Current: $34.34
Upside: +156.26%
Rocket Pharmaceuticals
Nov 7, 2025
Maintained: Buy
Price Target: $9
Current: $3.72
Upside: +141.94%
Larimar Therapeutics
Nov 5, 2025
Maintained: Buy
Price Target: $22
Current: $3.73
Upside: +490.60%
Tarsus Pharmaceuticals
Nov 5, 2025
Maintained: Buy
Price Target: $85 → $84
Current: $59.31
Upside: +41.63%
Nov 3, 2025
Maintained: Buy
Price Target: $54 → $67
Current: $71.21
Upside: -5.91%